The Company intends to pursue measures to cure the share price non-compliance, including through a reverse stock split of the Company's common stock, subject to stockholder approval, no later than at its next annual meeting of stockholders, if such action is necessary to cure the share price non-compliance.
The NYSE notification does not affect the Company's business operations or its Securities and Exchange Commission reporting requirements, and it does not conflict with or cause an event of default under any of the Company's material debt or other agreements.
Media Relations:
(972) 431-3400 or [email protected]
Follow @jcpnews on Twitter for the latest announcements and Company information.
Investor Relations:
(972) 431-5500 or [email protected]
###
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
